跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
王 志敏
前沿交叉科学研究院
h-index
992
引用
17
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2017
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(38)
指纹图谱
深入其中 Zhimin Wang 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Material Science
Nanocrystalline Material
100%
Tumor
50%
Nanoparticle
41%
Polyoxometalate
37%
Transition Metal
35%
Lanthanide Series
30%
Physical Property
15%
Chemical Property
15%
Stem Cell
12%
Nitrosative Stress
12%
Tomography
12%
Fiber Optics
12%
Macrophage
12%
Enzyme Activity
12%
Nanocomposites
12%
Transducer
12%
Ionic Liquid
12%
Flame Retardant
12%
Water Splitting
12%
Metal-Organic Framework
12%
Quantum Dot
12%
Contrast Medium
8%
Optical Property
6%
Membrane Structure
6%
Signal-to-Noise Ratio
6%
Epoxy
6%
Oxygen Evolution
5%
Medicine and Dentistry
Photoacoustic Tomography
37%
Lanthanide
16%
Biomedical Research
15%
Photomedicine
12%
Ion Channel
12%
Cancer Therapy
12%
Biological Marker
12%
Mediator
12%
Cardiovascular Monitoring
12%
Treatment Response
12%
Nanocomposite
12%
Dimethyl Sulfoxide
12%
Neoplasm
12%
Disease
12%
Tetramethylbenzidine
12%
Hindlimb
12%
Homeostasis
12%
Serositis
12%
Inflammatory Injury
12%
Combination Therapy
10%
Diagnosis
8%
Optical Imaging
6%
Genetic Engineering
6%
Adverse Event
6%
Therapy Effect
6%
Receptor Potential
6%
Biocompatibility
6%
Invasive Procedure
6%
Human Subject
6%
Blood Extract
6%
Hypoxia
6%
Blood Analysis
6%
Biological Target
6%
Side Effect
6%
Nanoparticle
5%
Glucose Transporter
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
32%
Upconversion Nanoparticle
16%
Fluorescent Dye
15%
Metal Complex
12%
Reactive Oxygen Metabolite
12%
Reactive Nitrogen Species
12%
Nanocomposite
12%
Copper Sulfide
12%
2,5-Dimethoxy-4-iodoamphetamine
12%
Infection
12%
Dimethyl Sulfoxide
12%
Tumor Microenvironment
12%
Hypoxia
12%
Carcinogenesis
12%
Nitroreductase
12%
Photothermal Therapy
9%
Disease
7%
Side Effect
7%
Combination Therapy
6%
Meningitis
6%
Blood Extract
6%
Biological Target
6%
Ferrous Ion
6%
Therapeutic Effect
6%
Monotherapy
6%
Glycan
5%
Bacterial Infection
5%
Pharmacokinetics
5%
Drug Development
5%
